Skip to main navigation Skip to search Skip to main content

MATR3 disruption in human and mouse associated with bicuspid aortic valve, aortic coarctation and patent ductus arteriosus

  • Fabiola Quintero-Rivera
  • , Qiongchao J. Xi
  • , Kim M. Keppler-Noreuil
  • , Ji Hyun Lee
  • , Anne W. Higgins
  • , Raymond M. Anchan
  • , Amy E. Roberts
  • , Ihn Sik Seong
  • , Xueping Fan
  • , Kasper Lage
  • , Lily Y. Lu
  • , Joanna Tao
  • , Xuchen Hu
  • , Ronald Berezney
  • , Bruce D. Gelb
  • , Anna Kamp
  • , Ivan P. Moskowitz
  • , Ronald V. Lacro
  • , Weining Lu
  • , Cynthia C. Morton
  • James F. Gusella, Richard L. Maas
  • Massachusetts General Hospital
  • University of California at Los Angeles
  • Harvard University
  • University of Iowa
  • Boston Children's Hospital
  • Boston University
  • Icahn School of Medicine at Mount Sinai
  • The University of Chicago
  • Brigham and Women’s Hospital

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Abstract

Cardiac left ventricular outflow tract (LVOT) defects represent a common but heterogeneous subset of congenital heart disease for which gene identification has been difficult. We describe a 46,XY,t(1;5)(p36.11;q31.2)dn translocation carrier with pervasive developmental delay who also exhibited LVOT defects, including bicuspid aortic valve (BAV), coarctation of the aorta (CoA) and patent ductus arteriosus (PDA). The 1p breakpoint disrupts the 50 UTR of AHDC1, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea. Am. J. Hum. Genet., 94, 784-789]. On the other hand, the 5q translocation breakpoint disrupts the 30 UTR of MATR3, which encodes the nuclear matrix protein Matrin 3, and mouse Matr3 is strongly expressed in neural crest, developing heart and great vessels, whereas Ahdc1 is not. To further establish MATR3 30 UTR disruption as the cause of the proband's LVOT defects, we prepared a mouse Matr3Gt-ex13 gene trap allele that disrupted the 30 portion of the gene. Matr3Gt-ex13 homozygotes are early embryo lethal, but Matr3Gt-ex13 heterozygotes exhibit incompletely penetrant BAV, CoA and PDA phenotypes similar to those in the human proband, as well as ventricular septal defect (VSD) and double-outlet right ventricle (DORV). Both the human MATR3 translocation breakpoint and the mouse Matr3Gt-ex13 gene trap insertion disturb the polyadenylation ofMATR3 transcripts and alterMatrin 3 protein expression, quantitatively or qualitatively. Thus, subtle perturbations in Matrin 3 expression appear to cause similar LVOT defects in human and mouse.

Original languageEnglish
Article numberddu004
Pages (from-to)2375-2389
Number of pages15
JournalHuman Molecular Genetics
Volume24
Issue number8
DOIs
StatePublished - Apr 15 2015

Fingerprint

Dive into the research topics of 'MATR3 disruption in human and mouse associated with bicuspid aortic valve, aortic coarctation and patent ductus arteriosus'. Together they form a unique fingerprint.

Cite this